US Patent 9260501 Peptide extended insulins
Patent 9260501 was granted and assigned to Novo Nordisk on February, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 29, 2007
Date of Patent
February 16, 2016
Patent Application Number
12312132
Patent Citations Received
Patent Inventor Names
Jan Markussen
0
Thomas Høeg-Jensen
0
Thomas Børglum Kjeldsen
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9260501 Peptide extended insulins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
